| ²é¿´: 373 | »Ø¸´: 1 | ||
[ÇóÖú]
΢Æ×ÇóÖú£¬¼±¼±¼±£¡ÔõôûÓÐÈ˰ïÖúÄØ ÒÑÓÐ1È˲ÎÓë
|
| 24.4,24.4,24.5,24.6,24.8,27.6,27.7,28.6,28.7,28.8,28.8,28.9,32.1,32.2,33.8,33.9,34.0,51.5,120.6,120.7,152.2,152.4,172.1,180.2,180.4 |
» ²ÂÄãϲ»¶
288Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ12È˻ظ´
¼ÆËã»ú11408£¬286·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏר˶322·Ö
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ÉϺ£º£Ñó´óѧ083200ʳƷѧ˶£¬Çóµ÷¼Á£¬½ÓÊÜÆäËûרҵ083200
ÒѾÓÐ5È˻ظ´
081200-11408-276ѧ˶Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ10È˻ظ´
313Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£©
ÒѾÓÐ14È˻ظ´
²ÄÁϹ¤³Ì302·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Óл¯ºÏÎï̼Æ×Êý¾ÝÈçÏ£¬Ç󻯺ÏÎï½á¹¹Ê½¡£ÇóÖúÇóÖú£¬¼±¼±£¬ÔÚÏߵȣ¬Ð»Ð»£¡½ð±Ò~~~~~~
ÒѾÓÐ6È˻ظ´
΢Æ×ÇóÖú£¬Íò·Ö¸Ðл¡£
ÒѾÓÐ3È˻ظ´
¼±¼±¼±~~΢Æ×ÇóÖú£¬Ð»Ð»O(¡É_¡É)Oлл
ÒѾÓÐ4È˻ظ´
΢Æ×ÇóÖú£¡¸Ð¼¤£¡
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖú лл´ó¼Ò
ÒѾÓÐ3È˻ظ´
podÊý¾Ý´¦ÀíÇóÖú
ÒѾÓÐ12È˻ظ´
΢Æ×ÇóÖú£¬¶àлÁË
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖú ³ê½ð15 °´ÕÕ¸ñʽҪÇóÁгöµÄ
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖú£¬Ìáǰлл£¡
ÒѾÓÐ3È˻ظ´
΢Æ×ÇóÖú£¬Ð»Ð»
ÒѾÓÐ4È˻ظ´
΢Æ×ÇóÖú3¸ö»¯ºÏÎï
ÒѾÓÐ3È˻ظ´
¹òÇó3¸ö΢Æ×Êý¾Ý£¬ÖÔÐĸÐл£¡
ÒѾÓÐ3È˻ظ´
ÇóÖú°¡£¬¼±¼±¼±£¬Ì×´Å·½Ã棬лл
ÒѾÓÐ10È˻ظ´
΢Æ×ÇóÖú£¡¼±¼±¼±£¬Ð»Ð»£¡
ÒѾÓÐ3È˻ظ´
¼±Çó΢Æ×¿â²éѯ£¡·Ç³£¸Ðл£¡
ÒѾÓÐ5È˻ظ´
΢Æ×ÇóÖú ¼±¼±¼±£¡£¡£¡
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ7È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý¿â²é»¯ºÏÎï
ÒѾÓÐ3È˻ظ´
ÇóÖúͨ¹ý΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´

ning-heng
Ìú³æ (ÕýʽдÊÖ)
- Ó¦Öú: 14 (СѧÉú)
- ½ð±Ò: 4676.4
- É¢½ð: 80
- Ìû×Ó: 337
- ÔÚÏß: 42.6Сʱ
- ³æºÅ: 2716254
- ×¢²á: 2013-10-11
- רҵ: Ò©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
1 . 1,2-di-(11'-hydroxyundecanoyl)-sn-glycero-3-dithiophosphocholine C30H60NO8PS2 ÏàËÆ¶È:62.9% The Journal of Organic Chemistry 2003 68 7298-7307 Design, Synthesis, and Evaluation of Water-Soluble Phospholipid Analogues as Inhibitors of Phospholipase C from Bacillus cereus Christopher L. Franklin, Hui Li, and Stephen F. Martin Structure 13C NMR ̼Æ×Ä£Äâͼ 2 . (5'S,8'R,1S)-Hexadecane acid-2-hydroxy-2-(2'-cyclohex-anyloxy-6',9'-dioxo-1',7'-dioxaspiro[4.4]non-8'-yl)-ethyl ester C31H52O8 ÏàËÆ¶È:61.5% Bioorganic & Medicinal Chemistry 2000 8 807-813 Inhibition of protein phosphatases by Michael adducts of ascorbic acid analogues with ¦Á,¦Â-unsaturated carbonyl compounds U.G Witt, J.E Schultz, M Dölker, K Eger Structure 13C NMR ̼Æ×Ä£Äâͼ 3 . compound 6g C13H18Cl2O ÏàËÆ¶È:60% Tetrahedron 2011 67 9844-9852 A flexible approach to hexahydronaphthalene-1-carboxylates Zhi Li, Celia Alameda-Angulo, B¨¦atrice Quiclet-Sire, Samir Z. Zard Structure 13C NMR ̼Æ×Ä£Äâͼ 4 . (R)-2-[(R)-9-bromo-1-(tert-butyldimethylsilanyloxy)non-3-enyl]hexacosanoic acid methyl ester C42H85BrO3Si ÏàËÆ¶È:60% Tetrahedron 2013 69 6285-6296 The synthesis of methoxy and keto mycolic acids containing methyl-trans-cyclopropanes Gani Koza, Maged Muzael, Richard R. Schubert-Rowles, Cornelia Theunissen, Juma'a R. Al Dulayymi, Mark S. Baird Structure 13C NMR ̼Æ×Ä£Äâͼ 5 . 1,2-di-(8'-hydroxyoctanoyl)-sn-glycero-3-dithiophosphocholine C24H48NO8PS2 ÏàËÆ¶È:60% The Journal of Organic Chemistry 2003 68 7298-7307 Design, Synthesis, and Evaluation of Water-Soluble Phospholipid Analogues as Inhibitors of Phospholipase C from Bacillus cereus Christopher L. Franklin, Hui Li, and Stephen F. Martin Structure 13C NMR ̼Æ×Ä£Äâͼ |
2Â¥2014-07-26 09:45:05














»Ø¸´´ËÂ¥